Novartis explains stance over India patent law challenge

Article Date: 27/02/2012 08:00
Novartis explains stance over India patent law challenge

Vacancy Search

Quick job search

Advanced Search

Latest News

NHS leaders unveil five-year plan for new-look service

NHS leaders unveil five-year plan for new-look service

Provisional NHS green light for Bayer's Xarelto

Provisional NHS green light for Bayer's Xarelto

Biogen stock hurt by Tecfidera rare brain infection case

Biogen stock hurt by Tecfidera rare brain infection case

GSK looks for £1 billion savings and plans IPO for ViiV

GSK looks for £1 billion savings and plans IPO for ViiV

J&J to spend $200 million to speed Ebola vaccine

J&J to spend $200 million to speed Ebola vaccine

NICE defends panels over conflict of interest claim

NICE defends panels over conflict of interest claim

Roche to spend 3 billion francs on Basel site

Roche to spend 3 billion francs on Basel site

NICE fast-tracks final 'yes' for GSK skin cancer drug

NICE fast-tracks final 'yes' for GSK skin cancer drug

Omeros hit by Huntington's trial suspension

Omeros hit by Huntington's trial suspension

Bavarian Nordic leaps ahead in Ebola race

Shares of the North American biotechs iBio, Tekmira Pharmaceuticals and Chimerix have soared and then deflated in the midst of the biggest-ever Ebola outbreak in the hope that their...
more news